Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)

Inclusion Criteria: * Hepatocellular Carinomas with diagnosis of pathology or cytology or consistent with China 2001 guideline of Clinical Diagnosis Hepatocellular Carinomas clinical stage（The Barcelona Liver Clinic staging system,BCLC B and C)，or can not receive surgical intervention * liver function:Child-Pugh A、B * PST 0-1（Eastern Cooperative Oncology Group Performance Score ,ECOG） * Lifespan≥6 months * First time to receive treatment * Can accept the follow up * informed consent was gotten * the number of lesion ≤ 5 Exclusion Criteria: * pregnant or lactation woman * emotional disturbance * serious heart ,lung disfunction or serious diabetes mellitus * serious reactiveness infections;（exp:type B or C hepatitis） * liver function :Child-Pugh Score C * thrombocyte\<6×109/L * diffuse HCC * widespread metastasis * serious atherosclerosis * acquired immunodeficiency syndrome;AIDS * thrombosis or thrombosis event in 6 months * renal inadequacy who need hemodialysis or peritoneal dialysis * with other tumors except basal cell carcinoma and carcinoma in situ of cervix * serious alimentary tract hemorrhage in 4 weeks